Effect of Devdali Nasya karma in the Management of Kamala (Jaundice): An Ayurvedic Perspective

Action of Luffa Echinata (Devdali)Nasya Karma in Kamla. - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087814

Enrollment

Registered

2025-05-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K769- Liver disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. S.Bilirubin Total level less then 15mg/dL 2. S.Bilirubin Direct level less then 5mg/dL 3. S.Bilirubin Indirect level less then 5mg/dL

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Ascites 3. Hepatitis B & C malfunctioning 4. Any of the hernia. 5. Cerebral pathology 6. GI disorders 7. Anorectal disorders 8. Orthopnea 9. Paroxysmal nocturnal dyspnea 10. Fever (infectious / non-infectious) 11. Respiratory disorders or involvement 12. Acute or Chronic renal failure 13. Musculoskeletal disorders i.e. sciatica, joint pains, bone and joint deformities. 14. Uncontrolled diabetes, uncontrolled hypertension, unstable angina. 15. Hypothyroidism or hyperthyroidism. 16. Decompensated Heart Failure. 17. Other systemic diseases

Design outcomes

Primary

Measure	Time frame
Reduction in S.Bilirubin level in the 24 hours after the first dose of Devdali NasyaTimepoint: Reduction in S.Bilirubin level in the 24 hours after the first dose of Devdali Nasya	—

Secondary

Measure	Time frame
First occurrence of normal level of S. Bilirubin & QOLTimepoint: Day - 1 Day - 2 Day - 3	—

Countries

India

Contacts

Public ContactDr Himanshu verma

Patanjali Ayurveda Hospital Patnjali Yogpeeth (Trust)

drcbdhanraj@gmail.com7396174582

Outcome results